November 22, 2010
ACT Gets FDA Go Ahead
By Brandon Butler
Marlborough-based Advanced Cell Technology has received government approval to move forward on clinical testing for an eye disorder treatment using stem cells.
ACT is developing a drug for Stargardt's Macular Dystrophy, which causes vision problems and can lead to blindness in children.
The company will test its stem-cell based treatment on 12 patients across the country. One of the test sites could include UMass Memorial Medical Center in Worcester.
Macular degeneration, which Stargardt's is classified as, impacts more than 30 million people in the United States and Europe, according to ACT.
WBJ Web Partners
Most Recent
Most Recent
0 Comments